Taiwan Liposome Company Overview

Taiwan Liposome Company Research & Development

Research & Development expenses for TLC.

Quarterly R&D Expenses

$220.09M

↓ 3.84% YoY

As of Jun 30, 2021

Annual R&D Expenses (TTM)

$989.71M

↑ 19.57% YoY

Trailing 12 months ending Jun 30, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin